Engin Ozkan to Cell Line, Tumor
This is a "connection" page, showing publications Engin Ozkan has written about Cell Line, Tumor.
Connection Strength
0.080
-
"Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein a (SIRPa) antagonists that enhance antibody-dependent cellular phagocytosis. J Biol Chem. 2015 May 15; 290(20):12650-63.
Score: 0.043
-
Engineered SIRPa variants as immunotherapeutic adjuvants to anticancer antibodies. Science. 2013 Jul 05; 341(6141):88-91.
Score: 0.019
-
Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15. Nat Immunol. 2012 Dec; 13(12):1187-95.
Score: 0.018